Vial sizes vary by vendor. Smaller bottles are usually 3 mL; larger bottles are often 10 mL. Match the label on the vial you actually bought, then use the calculator below if you need to adjust.
Overview
Tesamorelin (GHRH analog, FDA-approved for visceral fat) plus ipamorelin (selective secretagogue) — the stack pairs the two heaviest hitters of their classes. In this 10 mg blend each unit delivers 16.7 mcg of each peptide.
Preparation
Reconstitute the 10 mg vial with 3 mL of bacteriostatic water (BAC) for a ~3.33 mg/mL total (1.67 mg/mL each peptide). Refrigerate after mixing.
| Vial | BAC | Concentration |
|---|---|---|
| 10 mg | 3 mL | 3.33 mg/mL |
Protocol
| Period | Dose | Units (@ 3.33 mg/mL) | Frequency |
|---|---|---|---|
| Weeks 1–2 | 0.23 mL blend (≈ 380 mcg each / 0.77 mg total) | 23 units (0.23 mL) | 1x/day |
| Weeks 3–4 | 0.45 mL blend (≈ 750 mcg each / 1.5 mg total) | 45 units (0.45 mL) | 1x/day |
| Weeks 5–6 | 0.90 mL blend (≈ 1,500 mcg each / 3.0 mg total) | 90 units (0.90 mL) | 1x/day |
| Weeks 7–10 | 1.35 mL blend (≈ 2,250 mcg each / 4.5 mg total) | 135 units (1.35 mL) | 1x/day |
| Weeks 11–16 | 1.80 mL blend (≈ 3,000 mcg each / 6.0 mg total) | 180 units (1.80 mL) | 1x/day |
Cycle
8–16 week daily cycles, evening dosing. Because the blend is a fixed ratio, the volume is the dose — the table shows exactly what each injection delivers. Large volumes need a 3 mL syringe.